Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study published by The BMJ.
Feb 28, 2024
0
36
The success of mRNA vaccines against COVID-19 has unleashed a flood of interest in using the technology to create more vaccines and treatments for everything from rare diseases and infections to cancer.
Feb 28, 2024
0
47
Thanks to advancements in the development of patented synthetic human-like hearts first created at Michigan State, researchers can study human heart development and congenital heart disease on highly accurate models. This ...
Feb 24, 2024
0
20
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010.
Feb 19, 2024
0
1
Opioid exposure is associated with increased odds of spontaneous preterm birth, according to a study published online on Feb. 14 in JAMA Network Open.
Feb 15, 2024
0
0
The U.S. nationwide quality initiative Target: Stroke (TS) is associated with improvement in thrombolysis frequency, timeliness, and outcome, according to a study published online Feb. 7 in JAMA Network Open.
Feb 12, 2024
0
0
Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22. This is one of the highest antidepressant prescribing rates in the world.
Feb 9, 2024
0
11
A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed ...
Feb 8, 2024
0
17
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic ...
Feb 5, 2024
0
0
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor functions, which eventually leads to death within five years of its onset. This disease causes weakness and atrophy ...
Feb 1, 2024
0
0
